It's time to focus on mental health strategies that lean into refugees' strengths, researchers say
Professor Angela Nickerson has identified several strong protective and promotive factors that are associated with better ...
BioPharma Dive12d
Approval in hand, Bristol Myers sets out to sell first-of-its-kind schizophrenia drug
The results have been met with excitement, especially since substantial portions of the schizophrenia population don’t respond to or stay on other therapies. Yet doctors, while eager to have another ...
ScienceAlert19d
Scientists Identify Brain Signal Disruptions Behind Voices in Schizophrenia
A new study reveals a missing area of brain activity in the minds of people with schizophrenia who hear voices. The analysis of brain wave data suggests a combination of two neurological functions ...
ScienceAlert22d
First New Schizophrenia Treatment in Decades a Much-Needed Alternative
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant Bristol ...
BioSpace22d
The Making of BMS’ Cobenfy: From Alzheimer’s to Schizophrenia
While BMS is starting with schizophrenia, KarXT/Cobenfy’s journey may be far from over. A recent post-hoc analysis showed that a subset of patients in the pivotal Phase III EMERGENT-1 and EMERGENT-2 ...
USA Today25d
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
Time26d
FDA Approves the First New Schizophrenia Drug in Decades
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...
Medical Xpress26d
FDA approves new kind of drug for schizophrenia
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and. Drug Administration. Cobenfy (xanomeline/trospium chloride ...
WebMD26d
FDA Approves Revolutionary Schizophrenia Drug
Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication ...
Nature26d
Revolutionary drug for schizophrenia wins US approval
First genomic study of schizophrenia in African people turns up broken genes Other drug makers are likewise seeing the value of targeting muscarinic receptors, pursuing various strategies to ...
ABC News27d
FDA approves 1st new drug for schizophrenia in more than 30 years
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...
UPI27d
FDA approves new schizophrenia drug
Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...